Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.00
-0.15 (-0.55%)
At close: Feb 10, 2026

Formosa Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4,0995,6546,7005,9213,390-
Market Cap Growth
-20.73%-15.62%13.17%74.66%--
Enterprise Value
2,6124,0175,4725,8002,937-
Last Close Price
27.1537.4549.9550.5932.95-
PS Ratio
336.9839.44214.954502.47118.82-
PB Ratio
2.713.655.8812.678.62-
P/TBV Ratio
3.954.698.77105.56--
EV/Sales Ratio
214.7728.02175.534410.71102.95-
Debt / Equity Ratio
0.020.020.030.020.010.03
Asset Turnover
0.010.080.020.000.05-
Quick Ratio
9.508.574.896.2611.551.14
Current Ratio
9.578.734.996.5612.151.19
Return on Equity (ROE)
-4.77%-14.94%-40.04%-94.39%-135.15%-97.65%
Return on Assets (ROA)
-4.92%-5.72%-13.58%-30.45%-41.28%-29.46%
Return on Capital Employed (ROCE)
-8.60%-9.20%-19.30%-47.20%-56.80%-56.20%
Earnings Yield
-1.81%-3.55%-4.81%-6.86%-11.83%-
FCF Yield
-1.37%-2.40%-2.96%-5.85%-9.78%-
Buyback Yield / Dilution
-7.04%-13.48%-18.00%-13.70%-31.19%-8.70%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.